Boston Scientific Scimed, Inc.

Cerus Endovascular Limited

Stryker Ireland Technology, Ltd.

Csa Medical, Inc.

Scimed Life Systems, Inc.

Stryker Corporation

Cordis Corporation

Stryker European Holdings I LLC

Micro Medical Solutions, Inc.

Covidien LP

Stryker Nv Operations Limited

Cents Endovascular Limited

Boston Scientific Corporation

Boston Scientific Medical Device Limited

Cardinal Health Switzerland 515 Gmbh

Stephen A Griffin

Elaine Lim

Gregory Edwin Mirigian

Huey Chan

Brian M Hanley

Lex Philip Jansen

Rafael Cordero

Wei Li Fan

Nhan Hue To

Heather V Hawkes

Brent C Gerberding

Wendelin Maners

Ellen Sheets

David Sherrill

Amy Sarli

Yem Chin

Ronald A Sahatjian

Scott Raymond Smith

Peter L Dayton

David Christopher Majercak

David Douglas Grewe

Lee Guterman

Anthony R Tremaglio

Marc Davidson

Thomas Yung-Hui Chien

Alyssa J Dassa

Anthony F Tassoni, Jr

Masoud Molaei

Michael Losordo

James A Davidson

Eric B Stenzel

Sheng-ping Zhong

Richard Hudson

Kinh-Luan D Dao

Gregory Sullivan

Jennifer Jandak

Alain Cornil

Laila Al-Marashi

Roger Stevens

Daniel J Kalashian

Ashok Nageswaran

John Ortiz

Amiel Richard Aguilar

Robert Z Obara

Benedict Shia

Jim Davidson

Sergei Babko-Malyi

Greg Mirigian

Tina Ye

Mark Davidson

Ronald A Saharjian

Stephen M McCARTIN

Huey Quoc Chan

Michael Louis Losordo

Anthony F Tassoni

Alain c/o Scimed Life Systems Inc Cornil

Provided herein is an occlusion device for intrasaccular implantation and/or vascular occlusion comprising: (a) a substantially solid marker having a proximal end, and a distal end; and (b) a low profile resilient mesh body attached to the distal end of the marker, the body having a delivery shape and a deployed shape capable of conforming to aneurysm walls; wherein the body has a diameter greater than a diameter of an aneurysm to be treated. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.

Occlusion device

Provided herein are methods for protecting distal vessels from emboli during aspiration, the method comprising delivery and deployment of an emboli protection device which is advanced and placed distally relative to the clot burden and thus deep in the neurovascular bed until the device, once deployed, fully opposes a vessel wall creating a circumferential seal across the vessel. The methods utilizing the emboli protection device protect distal vasculature from vulnerable clot emboli which become dislodged during clot removal and/or aspiration and trapped in the emboli protection device.

Clot removal distal protection methods

Provided herein is an occlusion device comprising: (a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end; and (b) a resilient mesh body attached within the marker band, wherein the body is a length y, and wherein the body comprises a bolus of additional resilient mesh material of a length x, wherein y is greater than x, and wherein the body extends distally from the marker band having a first delivery shape and a second expandable deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.

Provided herein is an occlusion device comprising: (a) continuous mesh structure comprising a medial pinch point; (b) a resilient mesh disc-shaped body extending distally and outward from the medial pinch point; and (c) a compressible mesh carriage extending distally from the medial pinch point on an opposing side of the resilient mesh body of (b), wherein the compressible mesh carriage comprises a pinch point on each end of the carriage, wherein one of the pinch points is the medial pinch point of (a); wherein the continuous mesh structure has a first delivery shape and a second expandable deployed shape, and wherein the length (x) of the resilient mesh body is greater than the length (y) of the compressible mesh carriage in free air and in the deployed shape.

Provided herein is an occlusion device for implantation into a body lumen or aneurysm comprising, a continuous compressible mesh structure comprising axial mesh carriages configured end to end, wherein each end of each carriage is a pinch point in the continuous mesh structure. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device are also disclosed.

A cryosurgery system for application of medical-grade liquid nitrogen to a treatment area via a small, low pressure, open tipped catheter. The system includes a console, including a touch panel computer, a cryogen module, a suction module and an electronics module, and a disposable spray kit. Features include optional low cryogen flow setting to reduce the cryogen flow rate by 50%, improved cryogen flow consistency reducing pressure pulses and peaks, an integrated suction pump for improved consistency and self-checks, specified vent tube areas and corresponding maximum expected pressures during cryospray procedure; optional pressure sensing capability to monitor pressure during a treatment, and novel catheter designs of multilayer and flexible construction providing a variety of spray patterns.

Cryospray catheters

A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.

Method and system for consistent, repeatable, and safe cryospray treatment of airway tissue

Provided herein is an occlusion device comprising: (a) continuous mesh structure comprising a medial pinch point; (b) a resilient mesh disc-shaped body extending distally and outward from the medial pinch point; and (c) a compressible mesh carriage extending distally from the medial pinch point on an opposing side of the resilient mesh body of (b), wherein the compressible mesh carriage comprises a pinch point on each end of the carriage, wherein one of the pinch points is the medial pinch point of (a); wherein the continuous mesh structure has a first delivery shape and a second expandable deployed shape, and wherein the length (x) of the resilient mesh body is greater than the length (y) of the compressible mesh carriage in free air and in the deployed shape. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device disclosed herein are also disclosed.

Growing community of inventors

San Jose, CA, United States of America

Stephen A Griffin